Search
SOLACI Congress
HomeStructural heart diseaseValvular Aortic valve

Valvular Aortic valve

View Category

Structural heart disease

Valve Thrombosis After TAVR: Larger-Diameter Valves and No Warfarin as Predictors

There are limited data on the incidence, clinical implications, and predisposing factors of valve thrombosis in patients...
solaci -
Learn More
Structural heart disease

TAVR in Pure Aortic Regurgitation Is Associated with Lower Mortality Rates

This study summarizes all available evidence on transcatheter aortic valve replacement (TAVR) for the treatment of native...
solaci -
Learn More
Structural heart disease

Transcarotid TAVR Safety: Local or General Anesthesia?

Courtesy of Dr. Agustín Vecchia. Early transcatheter aortic valve replacement (TAVR) was characterized by high vascular complication rates...
solaci -
Learn More
Structural heart disease

Embolic Protection Devices Reduce the Risk of New Lesions During TAVR

The aim of this study was to investigate the efficacy and safety of cerebral protection devices during...
solaci -
Learn More
Structural heart disease

TAVI May Improve Cognitive Function in Patients with Prior Deterioration

This work studies cognitive evolution after transcatheter aortic valve implantation (TAVI). Previous smaller studies reported conflicting results...
solaci -
Learn More
Structural heart disease

Cerebral Protection in TAVR: Studies Presented at London Valves

SENTINEL One of the new devices assessed at London Valves was Sentinel, which is made up of two...
solaci -
Learn More
Mitral valve

Percutaneous Device Closure of PVL: An Alternative to Surgery

Paravalvular Leak (PVL) occurs in 5 to 17% of patients undergoing surgical valve replacement. Percutaneous device closure...
solaci -
Learn More
Structural heart disease

Late Mortality in TAVR Is Mainly Due to Non-Cardiac Causes

Transcatheter aortic valve replacement (TAVR) has revolutionized the management of high-risk patients with severe aortic stenosis. However,...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

AHA 2024 | VANISH2 Trial

Dr. Omar Tupayachi - 0
Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

Dr. Omar Tupayachi - 0
It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Dr. Omar Tupayachi - 0
Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy